Efficacy of zoledronic acid for the reduction of bone marrow tumor cells in breast cancer patients receiving adjuvant therapy

被引：1
|
作者：
Solomayer, EF
Fehm, T
Gebauer, G
Janni, W
Lück, HJ
Wallwiener, D
机构：
[1] Univ Tubingen, Frauenklin, Tubingen, Germany
[2] Univ Heidelberg, Frauenklin, D-6900 Heidelberg, Germany
[3] Klinikum Ludwig Maximilians Univ, Munich, Germany
[4] Hannover Med Sch, Frauenklin, Hannover, Germany
来源：
BONE | 2006年 / 38卷 / 03期
关键词：
D O I：
10.1016/j.bone.2006.01.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid as adjuvant therapy for women with early stage breast cancer and disseminated tumor cells in bone marrow
    Lin, A. Y.
    Park, J. W.
    Scott, J.
    Melisko, M.
    Goga, A.
    Moasser, M. M.
    Moore, D. H.
    Rugo, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Zoledronic acid as adjuvant therapy for women with early stage breast cancer and occult tumor cells in bone marrow.
    Lin A
    Park J
    Melisko M
    Goga A
    Moasser M
    Moore D
    Brissaud C
    Rugo H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S40 - S40
  • [3] Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
    Vidula, Neelima
    Greenberg, Sally
    Petrillo, Laura
    Hwang, Jimmy
    Melisko, Michelle
    Goga, Andrei
    Moasser, Mark
    Magbanua, Mark
    Park, John W.
    Rugo, Hope S.
    [J]. NPJ BREAST CANCER, 2021, 7 (01)
  • [4] Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
    Neelima Vidula
    Sally Greenberg
    Laura Petrillo
    Jimmy Hwang
    Michelle Melisko
    Andrei Goga
    Mark Moasser
    Mark Magbanua
    John W. Park
    Hope S. Rugo
    [J]. npj Breast Cancer, 7
  • [5] Zoledronic acid (ZA) as adjuvant therapy for women with early stage breast cancer and disseminated tumor cells (DTC) in bone marrow (BM)
    Lin, A.
    Park, J.
    Melisko, M.
    Goga, A.
    Moasser, M.
    Moore, D.
    Rugo, H.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 120 - 120
  • [6] Breast-Cancer Adjuvant Therapy with Zoledronic Acid
    Coleman, Robert E.
    Marshall, Helen
    Cameron, David
    Dodwell, David
    Burkinshaw, Roger
    Keane, Maccon
    Gil, Miguel
    Houston, Stephen J.
    Grieve, Robert J.
    Barrett-Lee, Peter J.
    Ritchie, Diana
    Pugh, Julia
    Gaunt, Claire
    Rea, Una
    Peterson, Jennifer
    Davies, Claire
    Hiley, Victoria
    Gregory, Walter
    Bell, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1396 - 1405
  • [7] Breast-Cancer Adjuvant Therapy with Zoledronic Acid
    van der Vliet, Hans J.
    Verheul, Henk M. W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02): : 188 - 189
  • [8] Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer:: Results at 4 years
    Slade, MJ
    Singh, A
    Smith, BM
    Tripuraneni, G
    Hall, E
    Peckitt, C
    Fox, S
    Graham, H
    Lüchtenborg, M
    Sinnett, HD
    Cross, NCP
    Coombes, RC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) : 94 - 100
  • [9] No Advantage for the entire Group of Patients with Breast Cancer by adjuvant Therapy with Zoledronic Acid
    Souchon, R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (12) : 1157 - 1158
  • [10] Efficacy of zoledronic acid for prevention of bone loss in early-stage breast cancer patients receiving adjuvant therapy: A meta-analysis of 13 randomized controlled trials
    Mei, Mei
    Xiang, Zijian
    Yang, Jinghua
    Xiang, Ruolan
    [J]. CURRENT PROBLEMS IN CANCER, 2020, 44 (02)
12345